About the Author
Jeannette Y. Wick, MBA, RPH, FASCP, is the director of the Office of Pharmacy Professional Development at the University of Connecticut School of Pharmacy in Storrs.
Careful selection of pharmacotherapy and close monitoring are crucial to ensuring safety and efficacy.
Across the country, bus drivers are dropping off buses full of adolescents at school, saying, “Have a great day, and remember these are the best years of your life!” Among the approximately 72 students on a school bus, there are statistically 10 to 15 who would probably disagree.1,2
In 2019, the American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, and Children’s Hospital Association collectively declared child and adolescent mental health a national emergency.3 Across the US, more than 5.3 million adolescents have been diagnosed with mental or behavioral health conditions, and approximately 20% have undiagnosed mental health disorders.1 Many adults think back to their middle and high school years and can empathize.
Among adolescent females, anxiety is more common than in males (20.1% vs 12.3%). Females are also more likely to experience depression (10.9% vs 6% in males).1 Adolescents who report adverse childhood experiences, come from lower socioeconomic status homes, or identify with minority groups are at greatest risk.4-6 The third most common mental illness in this population is behavior or conduct disorder, with males more likely to be diagnosed than females (8.2% vs 4.3%).1 Youths who have mental health problems are often unengaged in school, may be troubled or troublesome students, are frequently absent from school, or may deal with bullying. These youths experience isolation because they have trouble making or keeping friends.1
Jeannette Y. Wick, MBA, RPH, FASCP, is the director of the Office of Pharmacy Professional Development at the University of Connecticut School of Pharmacy in Storrs.
Many adolescents are diagnosed in primary care settings, so primary care providers must have evidence-based screening and treatment approaches that ask important questions and include feedback from caregivers.7,8 Like adults, youths with mental health disorders need 2 types of treatment: Behavioral health providers use behavioral or cognitive programs to help patients develop coping skills and reduce symptoms, whereas medical providers are the team’s prescribers.7,8
Once youth are diagnosed, providers need to work with them and their caregivers to determine an acceptable path back to good mental health. In youths whose symptoms are less severe, the health care provider, child, and child’s family may choose watchful waiting, self-care, brief interventions, or therapy crafted for the individual.9-11 In adolescents whose symptoms need immediate intervention, psychotherapy, psychosocial support, and sometimes inpatient admission provide the underpinning for pharmacotherapy to work.9-11 Ample evidence indicates that combining medication with counseling and psychotherapy is more effective than any single approach.12 In patients who have conduct disorder, most experts recommend management training for caregivers that helps them use positive reinforcement and increase parental warmth, patience, and understanding.13
Selection of the appropriate pharmacotherapy must consider the patient’s preferences and symptom constellation. Not all mental health medications haven been approved for this age group, and prescribers may need to rely on recommendations from professional organizations, recent research, or their experience. The Table12-15 provides guidance about medications that have evidence supporting their use.
Since the FDA applied a boxed warning to antidepressants concerning suicidality, many people are hesitant to have children and adolescents take these medications. Pharmacists need to stress that youths are at far higher risk of suicidal behaviors when they are depressed than when they are taking antidepressants. Careful monitoring of their behavior and good interdisciplinary support ensure the best outcomes.14 Pharmacists need to monitor young patients closely for adverse effects and adherence, remembering that many adolescents can be oppositional or think they do not need the medication. Using the lowest effective dose for the shortest period of time is an excellent approach. It is also notable that many states allow youths to seek mental health care without parental permission.16
Mental health disorders among children and adolescents continue to be more prevalent than ever, and early intervention is critical. Using a combination of cognitive behavioral therapy and medication can help youths believe that their middle and high school years really are some of the best years of their life.
10 days ago
Pharmacist Spotlight: Luke Witkowski, PharmD11 days ago
Product Updates for September 202511 days ago
FDA Approvals for August 202513 days ago
Pharmacists’ Roles Are Expanding RapidlyStay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
September 22nd 2025
September 22nd 2025